Johnson & Johnson (JNJ) posted notable strengths in their earnings Tuesday. Jeff Jonas points to the company's pharmaceuticals sector as the highlight, arguing the company has a great pipeline which can withstand tariffs. One overhang: the company's talc lawsuit. Jeff thinks Johnson & Johnson paying the $10 billion settlement is the best route it can make to move forward.